StAR-Related Lipid Transfer (START) Domain Containing 3 (STARD3) (Middle Region) Peptide
Quick Overview for StAR-Related Lipid Transfer (START) Domain Containing 3 (STARD3) (Middle Region) Peptide (ABIN5513416)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Sequence
- AVVDQILAQE ENWKFEKNNE YGDTVYTIEV PFHGKTFILK TFLPCPAELV
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti- STARD3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- STARD3 (StAR-Related Lipid Transfer (START) Domain Containing 3 (STARD3))
-
Background
-
This gene encodes a member of a subfamily of lipid trafficking proteins that are characterized by a C-terminal steroidogenic acute regulatory domain and an N-terminal metastatic lymph node 64 domain. The encoded protein localizes to the membranes of late endosomes and may be involved in exporting cholesterol. Alternative splicing results in multiple transcript variants.
Alias Symbols: CAB1, es64, MLN64
Protein Size: 445 -
Gene ID
- 10948
-
NCBI Accession
- NM_001165937, NP_001159409
-
UniProt
- Q14849
Target
-